The study also revealed that the administration of TEPA, a Cu chelator, initiated the degradation of PD-L1 and thereby inhibited tumor growth in a neuroblastoma xenograft mouse model, providing novel insights into the mechanism of tumor immune evasion. Here, CD274 is linked to neoplasm.